PPP1R26P4

Across TCGA pan-cancer cohorts, PPP1R26P4 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated PPP1R26P4 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher PPP1R26P4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PPP1R26P4 expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

CESC, MESO, and READ are the cancer types where PPP1R26P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	III,IV	0.091	0.755	<.001	72	view →
MESO	DFS	Tertile	All	0.107	0.396	.005	36	view →
READ	OS	Tertile	All	0.183	0.828	<.001	36	view →
THCA	DFS	Tertile	IV	0.027	0.937	<.001	33	view →
SKCM	DFS	Tertile	All	0.393	0.772	<.001	24	view →
LGG	DFS	Tertile	All	0.153	0.461	.007	24	view →
ESCA	DFS	Tertile	III,IV	0.289	0.462	.023	21	view →
LAML	DFS	Tertile	All	0.670	0.307	.013	18	view →
UCEC	DFS	Tertile	All	0.740	0.898	.022	18	view →
GBM	DFS	Tertile	All	0.145	0.269	.042	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

PPP1R26P4–CESC (OS)

Open the CESC breakdown →